Products for Research Use Only
RegisterLogin

MP07-66

CAT: 0804-HY-123794-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-123794-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MP07-66, a FTY720 analogue, is devoid of immunosuppressive effects and shows promising antitumor effects in chronic lymphocytic leukemia by disruption of the SET-PP2A complex leading to PP2A reactivation[1].
CAS Number
1938056-90-6
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mp07-66.html
Purity
99.86
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CCCCCCOC1=CC=C(CNCC(OCC)OCC)C=C1
Molecular Formula
C19H33NO3
Molecular Weight
323.47
Precautions
H315, H319, H335
References & Citations
[1]Zonta F, et al. Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. Blood. 2015;125 (24) :3747-3755.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-101599IP-66
HY-157215HDAC-IN-66
HY-150769ZLM-66
HY-178333HDAC6-IN-66
HY-119768(±) -BAK2-66
HY-163261HSD17B13-IN-66
HY-P2370CH-66
HY-P991072MB-66
HY-163780AChE-IN-66
HY-170536NLRP3-IN-66

Alternative Products

CatalogName
BA8123-100MP07-66
BA41291-01A 66
B5575-50SC 66
T210197-01NZ-66
T208356-01HDAC-IN-66
MBS3606328-01SC-66
sc-58597AChRγ (66)
OR1086425-01BDE 66

Popular Products